Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Efficacy of Hemostatic Agents”

686 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 686 results

Large-scale testing (Phase 3)Study completedNCT01788020
What this trial is testing

Efficacy of First Line DRC +/- Bortezomib for Patients With Waldenström's Macroglobulinemia

Who this might be right for
Waldenström's Macroglobulinemia
University of Ulm 202
Testing effectiveness (Phase 2)Ended earlyNCT01023880
What this trial is testing

Study to Determine the Maximum Tolerated Dose and Evaluate the Efficacy and Safety of CEP-18770 (Delanzomib) in Patients With Relapsed Multiple Myeloma Refractory to the Most Recent Therapy

Who this might be right for
Multiple Myeloma
Cephalon 62
Early research (Phase 1)Not Yet RecruitingNCT07113496
What this trial is testing

RN1201injection for Relapsed/Refractory CD19+/BCMA+ Hematologic Malignancies

Who this might be right for
Relapsed or Refractory B-cell Hematologic MalignanciesB-cell Acute Lymphoblastic Leukemia (B-ALL)Multiple Myeloma (MM)+3 more
The First Affiliated Hospital with Nanjing Medical University 27
Not applicableNot Yet RecruitingNCT06472479
What this trial is testing

LCAR-M61S and LCAR-M61D in Treatment of Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma
The First Affiliated Hospital with Nanjing Medical University 66
Large-scale testing (Phase 3)Study completedNCT00657488
What this trial is testing

Thalidomide 100 mg/Day Versus Thalidomide 400 mg/Day in Relapse Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 400
Testing effectiveness (Phase 2)Looking for participantsNCT05594797
What this trial is testing

Human BCMA Targeted T Cells Injection（BCMA CAR-T）for Subjects With R/R MM

Who this might be right for
Multiple Myeloma
Hrain Biotechnology Co., Ltd. 100
Testing effectiveness (Phase 2)Study completedNCT04463953
What this trial is testing

Zanubrutinib, Ixazomib and Dexamethasone in Patients With Treatment Naive Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenström Macroglobulinemia
Institute of Hematology & Blood Diseases Hospital, China 25
Early research (Phase 1)Looking for participantsNCT06185751
What this trial is testing

Safety and Efficacy of CS1 CAR-T (WS-CART-CS1) in Subjects With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Washington University School of Medicine 25
Very early researchLooking for participantsNCT06718270
What this trial is testing

CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Plasma Cell Leukemia

Who this might be right for
Relapsed/Refractory Multiple MyelomaRelapsed/Refractory Plasma Cell Leukemia
Shanghai Changzheng Hospital 24
Post-approval studies (Phase 4)Study completedNCT02844322
What this trial is testing

The Comparison of RCD Versus BCD in Newly Diagnosed Waldenström Macroglobulinemia

Who this might be right for
Waldenström Macroglobulinemia
Institute of Hematology & Blood Diseases Hospital, China 35
Testing effectiveness (Phase 2)UnknownNCT05712083
What this trial is testing

BCMA CAR-T Cell Therapy for Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple MyelomaNew Diagnosis Tumor
Zhejiang University 40
Not applicableLooking for participantsNCT07058727
What this trial is testing

Different Hemostatic Agents Used in Partial Pulpotomy on Pulp Survival and Postoperative Pain

Who this might be right for
Efficacy of Hemostatic AgentsPartial PulpotomyPostoperative Pain
Cukurova University 75
Early research (Phase 1)Looking for participantsNCT06934044
What this trial is testing

A Study Evaluating the Pharmacokinetics, Safety, and Efficacy of Cevostamab in Chinese Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Hoffmann-La Roche 20
Testing effectiveness (Phase 2)Study completedNCT01481194
What this trial is testing

ACVDL Treatment for Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Vejle Hospital 35
Not applicableNot Yet RecruitingNCT06720207
What this trial is testing

Efficacy of 68Ga-Pentixafor PET/MR in Detecting Non-Hodgkin Lymphoma and Multiple Myeloma Lesions

Who this might be right for
Non Hodgkin's LymphomaMultiple Myeloma (MM)
Shanghai East Hospital 30
Early research (Phase 1)Looking for participantsNCT07333430
What this trial is testing

Study of Naive HBI0101 CAR-T Therapy in Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma (MM)
Hadassah Medical Organization 60
Early research (Phase 1)Study completedNCT04322292
What this trial is testing

BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma

Who this might be right for
Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China 9
Early research (Phase 1)Ended earlyNCT05376345
What this trial is testing

BCMA-targeted LCAR-BCDR Cells in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Weijun Fu 24
Early research (Phase 1)WithdrawnNCT05513612
What this trial is testing

Novel CAR-T Cell Therapy in the Treatment of Hematopoietic and Lymphoid Malignancies

Who this might be right for
Acute Myeloid Leukemia (AML)B-cell Non-Hodgkin's Lymphoma (B-NHL)Multiple Myeloma (MM)+2 more
Shanghai Pudong Hospital
Testing effectiveness (Phase 2)Looking for participantsNCT06976476
What this trial is testing

Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia

Who this might be right for
Multiple MyelomaHypogammaglobulinemiaHypogammaglobulinemia, Acquired
Memorial Sloan Kettering Cancer Center 100
Load More Results